A Conservative bill granting Health Canada new powers to recall unsafe medicines will put a “chill” on industry, executives say. Representatives testifying at a Senate committee said the bill giving regulators access to confidential industry data must be amended: ‘It includes trade secrets’.
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
